Search Results1-20 of  31

  • 1 / 2
  • OHKURA Takako ID: 9000000170529

    Central Research Laboratory, Maruishi Pharmaceutical Co., Ltd. (2001 from CiNii)

    Articles in CiNii:3

    • single PCRとELISAによるチトクロームP450の定量法 (1996)
    • Metabolic Fate of Esmolol (2001)
    • Stereoselective Pharmacokinetics of Esmolol Enantiomers (2001)
  • OHKURA Takako ID: 9000000610897

    Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University (1997 from CiNii)

    Articles in CiNii:1

    • Detection of Proviruses and Viral RNA in the Early Stages of Feline Immunodeficiency Virus Infection in Cats: A Possible Model of the Early Stage of HIV Infection (1997)
  • OHKURA Takako ID: 9000001609770

    Subcommittee of Non-Clinical Evaluation, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (2005 from CiNii)

    Articles in CiNii:2

    • S3-6 Problems and Meanings of Genome-based Drug Discovery in Japanese Pharmaceutical Companies(SYMPOSIUM 3: BENEFITS OF PHARMACOGENOMICS/PHARMACOGENETICS IN PHARMACEUTICAL DEVELOPMENT)(Proceedings of the 31st Annual Meeting) (2004)
    • Current status of pharmaceutical industries in Japan on pharmacogenomics and toxicogenomics in 2005(Toxicogenomics, Toxicoproteomics, Proceedings of the 32nd Annual Meeting) (2005)
  • OHKURA Takako ID: 9000003094001

    Central Research Laboratory, Maruishi Pharmaceutical Co., Ltd. (2008 from CiNii)

    Articles in CiNii:7

    • Histopathological Changes of Streptozotocin-induced Painful Diabetes and Antihyperalgesic Effect of Capsaicin Cream in Rats (2008)
    • 2C-08 The Effects of Compound A - Inhalation on rat and the Recovery from the Renal Damage - Strain Diffefence and Clinical Markers (1997)
    • 2C-09 Semi-quantitative Analysis of Renal Tubular Injury Using Enzyme Immunohistochemistry and NIH Image (1997)
  • OHKURA Takako ID: 9000253263240

    Central Research Laboratory, Maruishi Pharmaceutical Co., Ltd. (2001 from CiNii)

    Articles in CiNii:1

    • Metabolic Fate of Esmolol. (2001)
  • OHKURA Takako ID: 9000257892766

    Spheroid Working Group in Safety Evaluation Forum|Maruishi Pharmaceutical Co., Ltd. (2014 from CiNii)

    Articles in CiNii:1

    • Evaluation of Human Hepatocytes Cultured by Three-dimensional Spheroid Systems for Drug Metabolism (2014)
  • OHKURA Takako ID: 9000261035934

    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (2013 from CiNii)

    Articles in CiNii:1

    • Potentials and limitations of nonclinical safety assessment for predicting clinical adverse drug reactions : correlation analysis of 142 approved drugs in Japan (2013)
  • OHKURA Takako ID: 9000283731408

    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (2012 from CiNii)

    Articles in CiNii:1

    • Concordance between non-clinical and clinical toxicity data I -Stratified analysis by the therapeutic category- (2012)
  • OHKURA Takako ID: 9000283731427

    Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (2012 from CiNii)

    Articles in CiNii:1

    • Concordance between non-clinical and clinical toxicity data II -Number of cases and prediction ability- (2012)
  • OHKURA Takako ID: 9000283731451

    Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (2012 from CiNii)

    Articles in CiNii:1

    • Concordance between non-clinical and clinical toxicity data V -Stratified analysis by the route of administration- (2012)
  • OHKURA Takako ID: 9000283731457

    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (2012 from CiNii)

    Articles in CiNii:1

    • Concordance between non-clinical and clinical toxicity data VI - Profile of the incidence stratified analysis (2012)
  • OHKURA Takako ID: 9000283731472

    Non-clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (2012 from CiNii)

    Articles in CiNii:1

    • Concordance between non-clinical and clinical toxicity data VII -Comparison of the exposure and the dose- (2012)
  • OHKURA Takako ID: 9000283731483

    Non-Clinical Evaluation Subcommittee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (2012 from CiNii)

    Articles in CiNii:1

    • Concordance between non-clinical and clinical toxicity Data VIII -Profile of the stratified analysis of non-clinical testing duration and animal species (2012)
  • OHKURA Takako ID: 9000283731578

    Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufactures Association|Department of Clinical Development, Maruishi Pharmaceutical Co., Ltd. (2012 from CiNii)

    Articles in CiNii:1

    • Concordance between non-clinical and clinical toxicity data - Survey of approved pharmaceuticals in Japan - (2012)
  • OHKURA Takako ID: 9000283731599

    Maruishi Pharmaceutical Co., Ltd.|Safety Evaluation Forum, Spheroid WG (2012 from CiNii)

    Articles in CiNii:1

    • In vitro drug metabolism and toxicology studies using human hepatocyte spheroid cultures (2012)
  • OHKURA Takako ID: 9000345266139

    Maruishi Pharmaceutical Co., Ltd.|Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, The Japan Pharmaceutical Manufacturers Association (2016 from CiNii)

    Articles in CiNii:1

    • Multi-endpoints' toxicology study: Current situation and perspective based on published literature and questionnaire survey (2016)
  • OHKURA Takako ID: 9000347138985

    Maruishi Pharmaceutical Co., Ltd.|Spheroid Working Group in Safety Evaluation Forum (2014 from CiNii)

    Articles in CiNii:1

    • Detection of drug-induced liver injury risk using human hepatocyte spheroid cultures (2014)
  • OHKURA Takako ID: 9000347140195

    Maruishi Pharmaceutical Co., Ltd.|Spheroid Working Group in Safety Evaluation Forum (2014 from CiNii)

    Articles in CiNii:1

    • Assessment of drug metabolizing enzyme activity in human hepatocyte spheroid cultures (2014)
  • OHKURA Takako ID: 9000347140364

    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association|Maruishi Pharmaceutical Co., Ltd. (2014 from CiNii)

    Articles in CiNii:1

    • Adverse drug reactions for 393 medicines newly approved in Japan in recent 14 years: hypertension and hypotension (2014)
  • OHKURA Takako ID: 9000347140488

    Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association|Maruishi Pharmaceutical Co., Ltd. (2014 from CiNii)

    Articles in CiNii:1

    • Concordance between non-clinical and clinical toxicity data -Prediction analysis of adverse reaction in the central nervous system by safety pharmacology studies- (2014)
  • 1 / 2
Page Top